Clinical Practice Guidelines for Surveillance Colonoscopy

Scope

Guideline ID: 
240
Topics: 
They focus on the appropriate use of colonoscopy in colorectal cancer (CRC) prevention and address three main questions: (i) when to repeat colonoscopy after adenomatous polypectomy; (ii) when to repeat colonoscopy after curative resection for colorectal cancer; and (iii) when to perform colonoscopy in those patients with inflammatory bowel disease, who have an increased risk of developing CRC.
Population Life Stage: 
Not stated
Why are you developing this guideline?: 

Surveillance colonoscopy contributes to the impact of the National Bowel Cancer Screening Program (NBCSP) by reducing subsequent cancer risk in those with screen-detected neoplastic lesions. As the 2011 Surveillance Colonoscopy Guidelines will expire in 2016, the Department of Health commissioned Cancer Council Australia to revise these guidelines.
Best practice in the management of surveillance colonoscopy in Australia has the potential to prevent cancer through removal of pre-malignant adenomas while avoiding inappropriately frequent requests for low-yield colonoscopy that are not supported by sound evidence. Such requests are likely to overwhelm colonoscopy services and delay follow-up investigation of NBCSP participants with positive screening tests.
It is therefore critical to have up-to-date, evidence-based guidelines available to:
• provide quality indicators for colonoscopy;
• guide recommendations on surveillance colonoscopy in those with increased risk of developing CRC;
• allow participants in the National Bowel Cancer Screening Program to progress smoothly through the screening pathway;
• help colonoscopists to better manage their patients and colonoscopy waiting lists and balance the demands of groups of patients with different procedural indications; and
• reduce deaths from bowel cancer overall.

What level of use is this guideline being developed for?: 
National
Is this a new guideline or a replacement/update for an existing guideline?: 
Guideline update
Setting of care: 
Not stated

Developer Details

Organisations: 
Contact Title: 
Head, Clinical Guidelines Network
First Name: 
Jutta
Surname: 
von Dincklage
Phone: 
(02) 8063 4116
Address: 

Level 14, 477 Pitt St

State: 
NSW
Collaborating Partners (if yes, please specify): 
No

Important Dates

Registration Date: 
Monday, 27 June 2016
Estimated Commencement Date: 
Friday, 15 July 2016
Estimated Completion Date: 
Sunday, 30 September 2018

Development Status

Current Development Status of Guideline: 
Guideline completed

Funding Details

What is funding status of this guideline?: 
Have secured funding (specify source)
Source of Funding: 
Department of Health